TWO SIGMA INVESTMENTS, LP - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 127 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$291,000
-74.0%
22,306
-60.9%
0.00%
-66.7%
Q2 2021$1,118,000
-82.2%
57,078
-80.6%
0.00%
-81.2%
Q1 2021$6,267,000
+790.2%
294,660
+1144.3%
0.02%
+700.0%
Q4 2020$704,000
+49.5%
23,681
+8.9%
0.00%0.0%
Q3 2020$471,000
-51.1%
21,742
-48.1%
0.00%
-33.3%
Q4 2019$963,000
+280.6%
41,922
+264.5%
0.00%
+200.0%
Q2 2019$253,000
-34.6%
11,500
-18.6%
0.00%0.0%
Q1 2019$387,00014,1290.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders